antivir
activ
recombin
felin
interferon
rfeifn
evalu
felin
enteropathogen
virus
felin
canin
cell
line
sensit
antivir
activ
rfelfn
vari
cell
type
feli
cam
whole
fetu
cell
sensit
crandel
felin
kidney
cell
sensit
found
madindarbi
canin
kidney
cell
vesicular
stomat
viru
use
challeng
viru
reduct
gener
ifn
dosedepend
consist
cell
continu
treat
rfelfn
pretreat
viral
challeng
compar
viru
control
cultur
cell
yield
rotaviru
felin
panleukopenia
viru
fplv
felin
caliciviru
felin
infecti
periton
coronaviru
reduc
rang
loglo
logo
logo
respect
cultur
continu
treat
u
rfelfn
yield
reduct
fplv
consid
part
attribut
inhibit
cell
growth
rfeifn
supplement
medium
antivir
activ
human
felin
interferon
ifn
felin
virus
veterinari
import
demonstr
vitro
human
alphaifn
huifna
felin
leukemia
viru
felv
jameson
essex
sen
et
al
huifna
felin
ifnfl
feifnfl
felin
herpesviru
fhv
felin
caliciviru
fcv
felin
infecti
periton
fip
viru
fulton
burg
weiss
weiss
oostromram
weiss
toiviokinnucan
feifnsa
felv
rodger
et
al
yamamoto
et
al
felfni
fcv
engelman
et
al
furthermor
vivo
experi
use
hulfna
alon
fip
weiss
et
al
felin
viral
rhinotrach
fvr
cocker
et
al
combin
antivir
drug
zidovudin
felv
infect
cat
cummin
et
al
zeidner
et
al
describ
review
rollinson
result
obtain
studi
indic
hulfna
may
use
drug
therapeut
use
fvr
cat
appli
auxiliari
rather
primari
treatment
fip
continu
efficaci
hulfna
therapi
felv
infect
appear
limit
due
induct
cytokinespecif
neutral
antibodi
recent
yanai
et
al
yanai
et
al
first
produc
recombin
felfn
rfelfn
silkworm
larva
bombyx
mori
use
baculoviru
vector
clone
cdna
fragment
code
ifn
cdna
librari
construct
mrna
extract
felin
lymphoblastoid
cell
establish
previous
yamamoto
et
al
amino
acid
sequenc
rfelfn
homolog
hulfna
suggest
atyp
nakamura
et
al
thu
mass
product
rfelfn
becom
possibl
evalu
experi
carri
purpos
studi
evalu
antivir
activ
rfelfn
felin
canin
cell
subsequ
challeng
felin
enteropathogen
virus
crandel
felin
kidney
crfk
cell
atcc
ccl
fell
cam
whole
fetu
cell
horzinek
et
al
madindarbi
canin
kidney
mdck
cell
atcc
ccl
use
determin
antivir
activ
rfeifn
cell
cultur
growth
medium
gm
consist
eagl
minimum
essenti
medium
emem
supplement
fetal
bovin
serum
fb
u
penicillin
g
per
ml
streptomycin
per
ml
g
amphotericin
per
ml
fetal
macacu
rhesu
monkey
kidney
cell
use
rotaviru
infect
assay
mochizuki
et
al
follow
virus
use
viral
challeng
vesicular
stomat
viru
vsv
refer
fhv
strain
mochizuki
et
al
refer
felin
pathogen
viru
rotaviru
felin
fip
coronaviru
fipv
fcv
felin
panleukopenia
viru
fplv
felin
enteropathogen
virus
new
jersey
strain
vsv
provid
nation
institut
anim
health
permiss
ministri
agricultur
forestri
fisheri
japanes
govern
vsv
grown
either
crfk
mdck
cell
cultur
use
canin
rotaviru
rs
strain
member
caninefelin
interspeci
genogroup
serial
passag
time
cell
cultur
adapt
use
challeng
kukh
strain
fipv
use
isol
spontan
fip
case
properti
correspond
criteria
type
iifip
induc
felin
coronaviru
pedersen
et
al
fc
strain
fcv
consid
enterictyp
fcv
mochizuki
fplv
tu
strain
mochizuki
et
al
use
rfelfn
lot
produc
silkworm
larva
yanai
et
al
suppli
toray
ind
inc
nihonbashi
muromachi
chuoku
tokyo
store
lyophil
vial
contain
unit
u
determin
use
vsv
felin
cell
yanai
et
al
stock
soluion
u
per
ml
rfelfn
prepar
ad
ml
emem
fb
mm
vial
store
dilut
use
preform
monolay
crfk
mdck
cell
cell
cultur
plate
come
new
york
treat
rfelfn
h
challeng
vsv
fhv
rotaviru
fipv
fcv
serial
tenfold
dilut
ifn
made
mm
cell
wash
mm
ml
dilut
rfelfn
ad
well
fplv
cell
gm
seed
plate
cultur
h
medium
replac
gm
contain
rfelfn
eight
well
treat
ifn
dilut
viru
control
vc
cultur
receiv
ifn
includ
condit
experi
h
pretreat
ifn
remov
well
cell
wash
emem
challeng
viru
ml
emem
ad
well
viru
dose
pfu
vsv
fhv
rotaviru
fipv
fcv
approx
hemagglutin
ha
unit
hau
fplv
h
adsorpt
monolay
wash
twice
emem
ml
mm
gm
fplv
alon
mm
gm
fplv
contain
amount
rfelfn
pretreat
ad
half
well
one
ifn
diltuion
respect
rotaviru
mm
contain
zg
per
ml
trypsin
type
sigma
chemic
comp
st
loui
instead
fb
plate
incub
maximum
cpe
appear
well
vc
cultur
plate
frozen
assay
viru
titer
plate
fplv
frozen
h
post
inocul
pi
thaw
cultur
fluid
centrifug
rpm
min
remov
cell
debri
result
superuat
appli
assay
viru
titer
vsv
fhv
rotaviru
fipv
fcv
determin
plaqu
assay
use
crfk
vsv
fhv
fcv
rotaviru
fipv
cell
report
previous
mochizuki
et
al
viru
titer
fplv
determin
ha
assay
describ
previous
mochizuki
hashimoto
difficult
determin
infect
fplv
precis
titer
express
throughout
present
paper
pfu
per
ml
hau
per
cultur
fluid
titer
repres
geometr
mean
eight
vc
well
four
ifn
treat
well
inhibitori
effect
rfeifn
growth
crfk
cell
examin
four
ml
ceil
suspend
per
ml
cell
densiti
gm
put
plastic
cell
cultur
dish
h
incub
medium
chang
gm
alon
gm
supplement
u
rfelfn
respect
dish
incub
h
number
viabl
cell
dish
count
trypan
blue
exclus
method
antivir
activ
rfelfn
celltyp
compar
use
vsv
felin
crfk
cell
line
treat
rfelfn
protect
vsv
challeng
tabl
vsv
grow
even
cell
pretreat
u
rfelfn
crfk
cell
appear
slightli
less
sensit
cell
antivir
activ
rfelfn
antivir
effect
gener
canin
mdck
cell
pretreat
maintain
viral
challeng
continu
treatment
u
rfelfn
data
shown
yield
fhv
cell
continu
treat
u
rfelfn
reduc
rang
logo
reduc
even
cell
treat
u
amount
differ
yield
reduct
cell
pretreat
continu
treat
cell
rfelfn
maximum
infect
titer
obtain
cell
cultur
serial
passag
adapt
around
pfu
howev
antirotaviru
effect
cell
treat
rfelfn
obvious
demonstr
compar
yield
vc
cultur
viru
grow
cell
continu
treat
rfelfn
grew
littl
cell
pretreat
shown
tabl
fplv
growth
tu
strain
crfk
cell
cultur
slightli
ifn
dosedepend
inhibit
cell
continu
treat
rfelfn
h
tabl
slight
reduct
obtain
cell
treat
rfelfn
reconfirm
separ
experi
slight
yield
reduct
obtain
cell
pretreat
rfelfn
compar
vc
cultur
yield
ifn
dosedepend
reduc
rang
loglo
pfu
continu
treat
cultur
crfk
cell
respect
reduct
yield
found
cell
cultur
receiv
pretreat
less
cell
cultur
continu
treat
sinc
kukh
strain
fipv
grow
effici
crfk
cell
cultur
antivir
activ
rfelfn
could
determin
cell
cultur
vc
cultur
show
maximum
cpe
h
pi
score
cell
detach
surfac
cultur
continu
treat
u
rfeifn
decreasingli
show
cpe
respect
yield
vc
cultur
logo
pfu
cell
treat
u
unexpectedli
logo
pfu
thu
reduct
loglo
respect
shown
tabl
inconsist
degre
cpe
viru
yield
observ
repeatedli
separ
experi
cell
pretreat
alon
inhibitori
effect
replic
fipv
detect
ml
cell
suspend
x
per
ml
cell
densiti
eagl
mem
supplement
fb
gm
put
plastic
cell
cultur
dish
h
incub
medium
chang
gm
alon
gm
rfelfn
respect
h
incub
viabl
cell
number
count
obtain
mean
two
dish
per
amount
rfelfn
reduct
obtain
ab
x
cell
number
gm
alon
b
cell
number
gm
rfelfn
data
express
mean
result
two
separ
experi
compar
control
cultur
growth
crfk
cell
gm
supplement
rfelfn
dosedepend
inhibit
tabl
howev
inhibitori
effect
differ
cell
type
growth
inhibit
cell
obvious
detect
medium
contain
u
amount
rfelfn
requir
time
amount
rfelfn
crfk
cell
caus
similar
degre
growth
inhibit
hostspeci
specif
ifn
gener
accept
howev
hulfnsa
show
specif
activ
also
heterolog
cell
produc
larg
quantiti
rel
low
cost
recombin
dna
techniqu
rhuifn
potenti
broad
spectrum
antivir
agent
veterinari
use
indic
vitro
vivo
experi
rhuifna
may
use
drug
therapeut
use
cat
viral
diseas
felv
fip
fvr
cocker
et
al
cummin
et
al
weiss
et
al
zeidner
et
al
disadvantag
heterogen
elicit
neutral
antibodi
anim
zeidner
et
al
rfeifn
examin
present
studi
first
massproduc
ifn
drug
cat
yanai
et
al
demonstr
antivir
activ
cell
treat
rfeifn
way
inferior
fhv
fcv
feifn
rhuifna
report
previous
fulton
burg
weiss
antivir
effect
detect
cell
continu
expos
rfelfn
cell
transient
treat
viral
challeng
appropri
exampl
interest
experi
fplv
growth
inhibit
fplv
shown
cell
continu
treat
u
rfeifn
littl
cell
pretreat
u
u
rfelfn
tabl
howev
wiedbrauk
et
al
claim
slight
reduct
yield
mink
parvovirus
cell
treat
high
concentr
u
per
ml
ifn
consid
signific
reason
high
ifn
concentr
inhibit
cell
growth
delay
entri
cell
phase
may
result
reduct
viru
replic
cell
autonom
replic
parvovirus
requir
one
cellular
function
gener
phase
cellular
divis
cycl
although
experiment
condit
present
studi
differ
previou
one
particularli
use
activ
divid
cell
reason
consid
yield
reduct
detect
present
studi
also
partli
attribut
inhibit
cell
growth
rfelfn
present
tabl
cell
line
cell
may
possess
ifnreceptor
crfk
cell
thu
sensit
antivir
activ
cellgrowth
inhibitori
effect
rfelfn
demonstr
consist
observ
enhanc
sensit
antifipv
effect
rhulfna
felfnfl
cell
note
compar
felin
diploid
cell
type
crfk
cell
weiss
toiviokinnucan
howev
replic
fipv
cell
treat
rfelfn
inhibit
much
report
previous
weiss
toiviokinnucan
may
influenc
factor
type
ifn
use
strain
differ
fipv
ifn
sensit
point
author
anoth
find
interest
inconsist
fipv
yield
degre
cpe
observ
cell
cultur
treat
rfelfn
unexpectedli
high
infect
obtain
cultur
show
low
degre
cpe
peculiar
find
agreement
previou
descript
fip
coronavir
particl
may
persist
intracellularli
without
show
cpe
ifntreat
cell
weiss
toiviokinnucan
present
studi
whole
cultur
includ
infect
cell
media
subject
viral
assay
therefor
one
probabl
explan
test
sampl
contain
extracellular
also
intracellular
virus
disrupt
cell
show
cpe
conclus
evalu
antivir
activ
newli
produc
rfelfn
felin
enteropathogen
virus
vitro
result
indic
certain
degre
antivir
effect
rotaviru
fipv
fcv
fplv
gener
felin
cell
treatment
rfelfn
thu
worthwhil
know
potenti
antivir
drug
given
oral
prophylaxi
enter
administr
rout
ifn
alreadi
describ
cat
cummin
et
al
